Literature DB >> 34499707

BACH2 is a putative T-cell lymphoma tumor suppressor that may play a role in product-derived CAR T-cell lymphomas.

Jay Daniels1,2, Jaehyuk Choi1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34499707      PMCID: PMC8703361          DOI: 10.1182/blood.2021012641

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.

Authors:  Joseph A Fraietta; Christopher L Nobles; Morgan A Sammons; Stefan Lundh; Shannon A Carty; Tyler J Reich; Alexandria P Cogdill; Jennifer J D Morrissette; Jamie E DeNizio; Shantan Reddy; Young Hwang; Mercy Gohil; Irina Kulikovskaya; Farzana Nazimuddin; Minnal Gupta; Fang Chen; John K Everett; Katherine A Alexander; Enrique Lin-Shiao; Marvin H Gee; Xiaojun Liu; Regina M Young; David Ambrose; Yan Wang; Jun Xu; Martha S Jordan; Katherine T Marcucci; Bruce L Levine; K Christopher Garcia; Yangbing Zhao; Michael Kalos; David L Porter; Rahul M Kohli; Simon F Lacey; Shelley L Berger; Frederic D Bushman; Carl H June; J Joseph Melenhorst
Journal:  Nature       Date:  2018-05-30       Impact factor: 49.962

2.  Super-enhancers delineate disease-associated regulatory nodes in T cells.

Authors:  Golnaz Vahedi; Yuka Kanno; Yasuko Furumoto; Kan Jiang; Stephen C J Parker; Michael R Erdos; Sean R Davis; Rahul Roychoudhuri; Nicholas P Restifo; Massimo Gadina; Zhonghui Tang; Yijun Ruan; Francis S Collins; Vittorio Sartorelli; John J O'Shea
Journal:  Nature       Date:  2015-02-16       Impact factor: 49.962

3.  CREST maps somatic structural variation in cancer genomes with base-pair resolution.

Authors:  Jianmin Wang; Charles G Mullighan; John Easton; Stefan Roberts; Sue L Heatley; Jing Ma; Michael C Rusch; Ken Chen; Christopher C Harris; Li Ding; Linda Holmfeldt; Debbie Payne-Turner; Xian Fan; Lei Wei; David Zhao; John C Obenauer; Clayton Naeve; Elaine R Mardis; Richard K Wilson; James R Downing; Jinghui Zhang
Journal:  Nat Methods       Date:  2011-06-12       Impact factor: 28.547

4.  CRISPR-engineered T cells in patients with refractory cancer.

Authors:  Edward A Stadtmauer; Joseph A Fraietta; Simon F Lacey; Carl H June; Megan M Davis; Adam D Cohen; Kristy L Weber; Eric Lancaster; Patricia A Mangan; Irina Kulikovskaya; Minnal Gupta; Fang Chen; Lifeng Tian; Vanessa E Gonzalez; Jun Xu; In-Young Jung; J Joseph Melenhorst; Gabriela Plesa; Joanne Shea; Tina Matlawski; Amanda Cervini; Avery L Gaymon; Stephanie Desjardins; Anne Lamontagne; January Salas-Mckee; Andrew Fesnak; Donald L Siegel; Bruce L Levine; Julie K Jadlowsky; Regina M Young; Anne Chew; Wei-Ting Hwang; Elizabeth O Hexner; Beatriz M Carreno; Christopher L Nobles; Frederic D Bushman; Kevin R Parker; Yanyan Qi; Ansuman T Satpathy; Howard Y Chang; Yangbing Zhao
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

Review 5.  The role of AP-1 and epigenetics in ALCL.

Authors:  Ana-Iris Schiefer; Paul Vesely; Melanie R Hassler; Gerda Egger; Lukas Kenner
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

6.  Genomic landscape of cutaneous T cell lymphoma.

Authors:  Jaehyuk Choi; Gerald Goh; Trent Walradt; Bok S Hong; Christopher G Bunick; Kan Chen; Robert D Bjornson; Yaakov Maman; Tiffany Wang; Jesse Tordoff; Kacie Carlson; John D Overton; Kristina J Liu; Julia M Lewis; Lesley Devine; Lisa Barbarotta; Francine M Foss; Antonio Subtil; Eric C Vonderheid; Richard L Edelson; David G Schatz; Titus J Boggon; Michael Girardi; Richard P Lifton
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

7.  BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers.

Authors:  Rahul Roychoudhuri; David Clever; Peng Li; Yoshiyuki Wakabayashi; Kylie M Quinn; Christopher A Klebanoff; Yun Ji; Madhusudhanan Sukumar; Robert L Eil; Zhiya Yu; Rosanne Spolski; Douglas C Palmer; Jenny H Pan; Shashank J Patel; Derek C Macallan; Giulia Fabozzi; Han-Yu Shih; Yuka Kanno; Akihiko Muto; Jun Zhu; Luca Gattinoni; John J O'Shea; Klaus Okkenhaug; Kazuhiko Igarashi; Warren J Leonard; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2016-05-09       Impact factor: 25.606

8.  PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.

Authors:  Tim Wartewig; Zsuzsanna Kurgyis; Selina Keppler; Konstanze Pechloff; Erik Hameister; Rupert Öllinger; Roman Maresch; Thorsten Buch; Katja Steiger; Christof Winter; Roland Rad; Jürgen Ruland
Journal:  Nature       Date:  2017-11-15       Impact factor: 49.962

9.  Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.

Authors:  Joonhee Park; Jay Daniels; Tim Wartewig; Kimberly G Ringbloom; Maria Estela Martinez-Escala; Sara Choi; Jane J Thomas; Peter G Doukas; Jingyi Yang; Caroline Snowden; Calvin Law; Yujin Lee; Katie Lee; Yancong Zhang; Carly Conran; Kyle Tegtmeyer; Samuel H Mo; David R Pease; Balaji Jothishankar; Pui-Yan Kwok; Farah R Abdulla; Barbara Pro; Abner Louissaint; Titus J Boggon; Jeffrey Sosman; Joan Guitart; Deepak Rao; Jürgen Ruland; Jaehyuk Choi
Journal:  Blood       Date:  2021-10-07       Impact factor: 25.476

10.  Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.

Authors:  Jay Daniels; Peter G Doukas; Maria E Martinez Escala; Kimberly G Ringbloom; David J H Shih; Jingyi Yang; Kyle Tegtmeyer; Joonhee Park; Jane J Thomas; Mehmet E Selli; Can Altunbulakli; Ragul Gowthaman; Samuel H Mo; Balaji Jothishankar; David R Pease; Barbara Pro; Farah R Abdulla; Christopher Shea; Nidhi Sahni; Alejandro A Gru; Brian G Pierce; Abner Louissaint; Joan Guitart; Jaehyuk Choi
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

View more
  1 in total

Review 1.  The Past, Present, and Future of Non-Viral CAR T Cells.

Authors:  Alex Moretti; Marianna Ponzo; Charles A Nicolette; Irina Y Tcherepanova; Andrea Biondi; Chiara F Magnani
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.